
Opinion|Videos|July 29, 2024
Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria
A panel of experts discuss the healthcare specialties that become involved in treating patients with CSU.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- Which healthcare specialties are involved in managing patients with CSU, and how can multidisciplinary care be optimized?
- What are the comorbidities that are most seen in patients with CSU, and how do these affect your management plan?
Advertisement
Related to this article

Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.

The once weekly self-injected treatment is the first dual-binding nanobody C5 inhibitor approved for adults with AChR antibody-positive gMG.

Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.

Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.

Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Dexmedetomidine Sublingual Film as At-Home Agitation Therapy
2
Menopause Benefit Design Should Prioritize Access, Total Cost of Care
3
Ribupatide Yields Up to 17.7% Weight Loss in Phase 3 GEMINI-1 Trial
4
FDA Approves Weekly Gefurulimab for Generalized Myasthenia Gravis
5


